Domain specificity of the human antibody response to Bacillus anthracis protective antigen.
about
Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assaysVaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro.Identification of peptide sequences as a measure of Anthrax vaccine stability during storage.An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor.Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax.Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.Mechanism of lethal toxin neutralization by a human monoclonal antibody specific for the PA(20) region of Bacillus anthracis protective antigen.MHC class II and non-MHC class II genes differentially influence humoral immunity to Bacillus anthracis lethal factor and protective antigen.Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthraxFrequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbedAnthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.A heterologous helper T-cell epitope enhances the immunogenicity of a multiple-antigenic-peptide vaccine targeting the cryptic loop-neutralizing determinant of Bacillus anthracis protective antigen.The promise and challenge of epitope-focused vaccines.
P2860
Q28383562-DAFE6BE6-708F-4E20-BF96-DA1F06BE6320Q34289924-60815505-A9F5-4A90-AC80-A48F3266E36DQ34290957-39436C40-23CA-4705-8BFC-540925AA2406Q34433313-E3C3570D-8384-46D2-817F-75C3DDC58E9EQ34483688-41C32439-E56D-4926-AF77-F0F099AB1BBCQ35031839-9D016860-1B61-4CE4-BCAE-083B39DE1D55Q35341887-CBBF5164-742F-412E-9376-240A5E38E0FAQ35459294-ACBDD987-9B6B-4E19-A586-1FE8C27F59A5Q36482706-66C32F0A-A297-4E04-AE40-89091D9C5CFFQ36668524-FDD76C7F-541F-47E5-B23F-897715B39153Q37191250-C75AC131-3372-46AA-B1C4-3FC0B53C8B96Q37404847-568D76E7-A6FD-4952-84D6-CC2913B34A24Q37451219-95E0DFEB-4084-4377-A56A-4119F625F0E3Q40722956-4C5F99FF-A0C1-4FC4-9597-B6F7152A83B4
P2860
Domain specificity of the human antibody response to Bacillus anthracis protective antigen.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Domain specificity of the huma ...... anthracis protective antigen.
@en
type
label
Domain specificity of the huma ...... anthracis protective antigen.
@en
prefLabel
Domain specificity of the huma ...... anthracis protective antigen.
@en
P2093
P2860
P1433
P1476
Domain specificity of the huma ...... anthracis protective antigen.
@en
P2093
Anuska Ullal
Donald C Reason
Jianhui Zhou
Jinying Sun
Justine Liberato
P2860
P304
P356
10.1016/J.VACCINE.2008.05.023
P407
P577
2008-06-02T00:00:00Z